Neurologists Turn to Telemedicine During Coronavirus Sheltering
Dr. Aaron Boster assessed the gait of his multiple sclerosis patient, who walked forward and back. Earlier, he had checked…
Articles by Ed Tobias
Online Coronavirus Screening May Not Be Ready for Prime Time
A number of websites are currently offering online coronavirus screening. These aren’t a full-scale test. The online sites read symptoms…
MS News that Caught My Eye Last Week: Coronavirus and DMTs, Gilenya and Pediatric MS, Ponesimod for RRMS, Cannabis for Spasticity
I’m starting this week by linking to our Coronavirus COVID-19 Information section on the Multiple Sclerosis News Today Forums. My…
Have You Tested Positive for Coronavirus with MS?
What happens if you have MS and you’ve tested positive for COVID-19? How will the disease affect your disease-modifying therapies…
MS News that Caught My Eye Last Week: Coronavirus Updates, MD1003 Trial Fails to Meet Goals, Sativex and Spasticity Relief, NurOwn Trial Site Announced
Second Phase 3 Trial of MedDay’s MD1003 for Progressive MS Fails to Meet Goals This is disappointing news about…
Guidelines for DMT Use as COVID-19 Spreads
People with multiple sclerosis have unique concerns about the new coronavirus and the COVID-19 disease that it causes. Many of…
MS News that Caught My Eye Last Week: Coronavirus FAQs, Diet, Ozanimod Study, High-dose Vitamin D
FAQs About Coronavirus and MS As the coronavirus that causes the COVID-19 disease spreads around the world, people with…
FDA Approval of Investigational DMT Ozanimod May Be Weeks Away
By the end of this month, another disease-modifying therapy (DMT) for…
MS News that Caught My Eye Last Week: Remyelination Research in Animal Models, Depression and Neurological Function, Ofatumumab Approval Moves Closer
In this column, I’ll be highlighting some of the research presented at this year’s Americas Committee for Treatment and Research…
MS Is a Rare Disease? I Think Not
Feb. 29 is Rare Disease Day. It’s a day on which those in the rare disease community attempt to…
MS News that Caught My Eye Last Week: New Baclofen Pump, Bone Marrow Transplant Study, Bladder Problems and Life Quality, Urinary Diversion Surgery
Flowonix’s Prometra II Pump System Receives FDA Approval for Use with Intrathecal Baclofen This new pump could be a…
Myeliviz Brings Hope for Faster MS Diagnosis
Myeliviz is the name of a new compound approved for a clinical trial in the U.S. that has the…
MS News that Caught My Eye Last Week: Report on Ocrevus Use, Cognitive Decline in MS, Gold Nanocrystals and Remyelination Study
Ocrevus Use Rises Among New Starters with RRMS, Loses Ground to Other Therapies in PPMS Ocrevus (ocrelizumab) bolted out…
Smoking and MS: Not a Good Match
Some interesting statistics about people with multiple sclerosis in the U.K. have been released by Public Health England. The…
MS News that Caught My Eye Last Week: Methionine, MSCT, Spinal Fluid, and BTK Blocker Studies
Dietary Changes May Delay Development and Progression of MS, Study Finds Methionine is an amino acid found in meat,…
Bladder Problems Keep Many of Us Looking for the Loo
Are you frequently up at night for bathroom trips? When you’re outside, are you always looking for a loo? You’re…
MS News that Caught My Eye Last Week: Epstein-Barr, UTI Factors, New Myelin Imaging Agent, Nerve Impulses and Demyelination
Epstein-Barr Virus and Certain Genes Interact in Ways That Can Promote MS, Study Finds Much has been written over…
Rising MS Medication Costs Mean Some Patients Are Skipping Doses
Forced by medication costs to choose between regularly taking their medications…
MS News that Caught My Eye Last Week: Mayzent for SPMS Approved in EU, Memory Training, Trial of Music-based Product to Improve Walking
Mayzent Helps Regulate the Immune System in SPMS, Study Shows Mayzent (siponimod) is one of several disease-modifying treatments that…
April Hester Is Lacing Up Her MS Hiking Boots Again
When I wrote about April Hester two years ago, she…
MS News that Caught My Eye Last Week: High Cost of MS Meds; MS Progression, Relapse, and DMT Timing; Remyelinating Therapy Trial; Myelin Regeneration Mouse Study
Almost Half of MS Patients Change or Stop DMT Due to High Financial Burden, Survey Shows I frequently see…
Stem Cells Versus DMTs: MS Treatments Go Head to Head
People with multiple sclerosis have been waiting for this: A full-scale clinical trial testing the effectiveness of stem cell transplantation…
MS News that Caught My Eye Last Week: AHSCT Trial Enlisting, Interferon-beta and Pregnancy, Probiotics, Language and Brain Health
New Trial Compares Stem Cell Treatment to Available Therapies for Severe Relapsing MS This is a biggie. The U.S.
I Was Seconds Away from Calling the Medics
My nose started running about a week before the sledgehammer hit.
Who’s Willing to Accept More DMT Risk, You or Your Neuro?
As more high-efficacy disease-modifying therapies (DMTs) are being made available, people with multiple sclerosis have to decide how much risk…
MS News that Caught My Eye Last Week: US Patent for Remyelination Therapy, Tysabri and Inflammation, Canada Funding Mavenclad
MetP Pharma Awarded US Patent for Potential Remyelination Therapy Mention remyelination and the reaction from most of us with…
Have You Joined the Conversations in Our MS Forums?
About a year and a half ago, Multiple Sclerosis News Today introduced a forums section. It’s a great place…
MS News that Caught My Eye Last Week: Gilenya Generics, MS Pain and Fatigue Toolkit, Profit Drives MS Meds Prices, MS and Sugar Link
FDA Approves Three Generic Versions of Novartis’ Gilenya for Treating Relapsing MS It’s always nice to hear about generics…
I’ve Had Success with the Bioness L300 Go This Time Around
I used the Bioness L300, a functional electrical stimulation (FES) device, for about seven years to counter my left foot…
MS News that Caught My Eye Last Week: Immunoadsorption, MS Therapies Approval, Cannabis-based Capsules for Study, Pregnancy and MS
Immunoadsorption May Be Superior to Plasma Exchange in Treating Steroid-resistant Relapses in MS Steroids may be an effective treatment…